Synapse - Works

Results (2899)

Long term follow up of patients with relapsed/refractory systemic light chain (AL) amyloidosis treated with bendamustine and dexamethasone in a phase 2 study

Meeting Abstract

Lagos, G. G.; Lentzsch, S.; Comenzo, R. L.; Zonder, J. A.; Osman, K.; Gould, J.; Tsai, W. Y.; Pregja, S.; Reyna, M.; Raza, S.; more...
Blood (2017)

Fulltext@MSK | Save

PD-L1 is regulated by interferon gamma and interleukin 6 through STAT1 and STAT3 signaling in cutaneous T-cell lymphoma

Meeting Abstract

Kil, S. H.; Estephan, R.; Sanchez, J.; Zain, J. M.; Kadin, M. E.; Young, J. W.; Rosen, S. T.; Querfeld, C.
Blood (2017)

Fulltext@MSK | Save

MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
Blood (2017)

Fulltext@MSK | Save

Assessment of a multi-cytokine profile by a novel biochip-based assay reveals unique correlation patterns with immune reconstitution after cord blood transplantation in adults

Meeting Abstract

Karantanos, T.; Kim, H. T.; Li, L.; Cutler, C.; Antin, J. H.; Ballen, K.; Ritz, J.; Politikos, I.; Boussiotis, V. A.
Blood (2017)

Fulltext@MSK | Save

Clinical and pathological features of B-cell acute lymphoblastic leukemia following maintenance treatment with lenalidomide for multiple myeloma

Meeting Abstract

Geyer, M. B.; Shaffer, B. C.; Landau, H.; Hassoun, H.; Famulare, C.; Roshal, M.; Dogan, A.; Arcila, M. E.; Park, J. H.
Blood (2017)

Fulltext@MSK | Save

A cost-benefit analysis of bortezomib, lenalidomide, and bortezomib/lenalidomide combination therapy for newly diagnosed multiple myeloma

Meeting Abstract

Fiala, M. A.; Wildes, T. M.; Shah, G. L.; Ghobadi, A.; Schroeder, M. A.; Stockerl-Goldstein, K. E.; Vij, R.
Blood (2017)

Fulltext@MSK | Save

Final analysis of the phase I/II study of CC-486 (oral azacitidine) maintenance therapy after allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS)

Meeting Abstract

de Lima, M.; Oran, B.; Champlin, R. E.; Papadopoulos, E. B.; Giralt, S. A.; Scott, B. L.; William, B. M.; Hetzer, J.; Hubbell, B.; Skikne, B. S.; more...
Blood (2017)

Fulltext@MSK | Save

High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL

Meeting Abstract

Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
Blood (2017)

Fulltext@MSK | Save

Characterizing ionizing radiation exposure after T-cell depleted allogeneic hematopoietic cell transplantation

Meeting Abstract

Cho, C.; Maloy, M.; Devlin, S. M.; Aras, O.; Castro-Malaspina, H. R.; Dauer, L. T.; Jakubowski, A. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Perales, M. A.; more...
Blood (2017)

Fulltext@MSK | Save

Efficacy of donor lymphocyte infusion in CD34+ selected allogeneic hematopoietic stem cell transplant for myeloid and lymphoid malignancies: A single center experience

Meeting Abstract

Bryant, A.; Devlin, S. M.; Castro-Malaspina, H. R.; Jakubowski, A. A.; Maloy, M.; Papadopoulos, E. B.; Giralt, S. A.; Perales, M. A.
Blood (2017)

Fulltext@MSK | Save